Senior Director, Team Lead, CDK4/6 Portfolio, US Breast Cancer
Pfizer
This listing was originally posted on Pfizer's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moROLE SUMMARY
Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you—across teams, roles, and the Pfizer enterprise. Join us to make history — for patients, for their families, for the future.
Breast cancer is the most common cancer affecting women in the US, and IBRANCE, our first-in-class CDK 4/6 inhibitor, has been prescribed to ~200,000 patients in the US since launch. In 2026, IBRANCE contributed >$2B in net revenue to Pfizer Oncology and continues to be a market leader despite intensifying competition. With the June 2026 FDA approval of the PATINA HER2+ indication, IBRANCE is now the only CDK4/6 inhibitor indicated for HR+ metastatic breast cancer regardless of HER2 status.
The next three years are the most consequential in the history of Pfizer’s breast cancer business. IBRANCE faces IRA effectuation and LOE in 2027, and atirmociclib, our CDK4-selective inhibitor, is the portfolio’s planned successor. Phase 2 randomized results from the FOURLIGHT-1 study of atirmociclib, plus fulvestrant in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer (MBC) who had received prior CDK 4/6 inhibitor-based treatment were presented at ESMO. These results further support atirmociclib as a potential first-in-class cell cycle inhibitor backbone for HR+, HER2- MBC and Pfizer’s development strategy in earlier lines of therapy. A Phase 3 study in frontline MBC is ongoing and an additional Phase 3 study in early breast cancer is planned to evaluate atirmociclib in combination with giredestrant, an investigational oral selective oestrogen receptor.
The same oncologists, accounts and treatment decisions are involved in both. This is a P&L and people-management leadership role that demands a strong enterprise leader. The colleague who leads this team will set a multi-year strategic vision, make thoughtful trade-off and resource prioritization decisions for both brands, and influence senior leadership across the wider organization. The role leads that transition as one integrated strategy: maximizing IBRANCE value through the PATINA launch/10 year heritage campaign, IRA and LOE while building the market, evidence and organization that atirmociclib will need.
The IBRANCE and atirmociclib commercial leader will pave the way internally and guide the cross functional team to innovate in all aspects of engagement across all stakeholder groups.
ROLE RESPONSIBILITIES
This Senior Director, Team Lead role reports to the VP, US Breast Cancer Franchise Lead and is an excellent opportunity for an experienced, collaborative and strategic leader to own the IBRANCE P&L and the atirmociclib pre-launch investment plan: own forecasting, OpEx and resource allocation, manage the revenue and expense trade-offs of LOE, and ensure every dollar released from IBRANCE is redeployed deliberately against portfolio priorities. The role leads a team of 6-8 HCP & patient marketers at the Director and Sr. Manager level. Atirmociclib is a critical launch for the Oncology portfolio over the next 5 years.
3. Own the integrated patient and advocacy strategy for HR+ve disease
BASIC QUALIFICATIONS
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including the ability to influence and collaborate with peers, develop and coach others, and oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
PREFERRED QUALIFICATIONS
Non-Standard Work Schedule, Travel or Environment Requirements
Other Job Details:
Last Date to Apply for Job: November 30th, 2026
Additional Location Information: New York, NY; Collegeville, PA
Eligible for Relocation Package: No
Position is hybrid and will require to work 2 to 3 days per week on site
#LI-PFE
The annual base salary for this position ranges from $230,900.00 to $384,800.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.
This role is posted in multiple locations. If you are applying for the role in an secondary job posting location where pay transparency regulations apply, your Talent Advisor will share the local pay information with you during the first interview.
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Pfizer endeavors to make www.pfizer.com/careers accessible to all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process and/or interviewing, please email disabilityrecruitment@pfizer.com. This is to be used solely for accommodation requests with respect to the accessibility of our website, online application process and/or interviewing. Requests for any other reason will not be returned.
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.
Marketing and Market Research
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Pfizer?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Solid Oral Dosage Forms
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo